41 studies found for:    "Cryptococcosis"
Show Display Options
Rank Status Study
21 Completed An Open, Non-Comparative Study of Intravenous and Oral Fluconazole in the Treatment of Acute Cryptococcal Meningitis
Conditions: Meningitis, Cryptococcal;   HIV Infections
Intervention: Drug: Fluconazole
22 Completed SCH 39304 as Therapy for Acute Cryptococcal Meningitis in HIV-Infected Patients Followed by Maintenance Therapy
Conditions: Meningitis, Cryptococcal;   HIV Infections
Intervention: Drug: SCH 39304
23 Completed Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Maintenance Treatment for the Prevention of Relapse of Cryptococcal Meningitis in Patients With Acquired Immunodeficiency Syndrome
Conditions: Meningitis, Cryptococcal;   HIV Infections
Interventions: Drug: Fluconazole;   Drug: Amphotericin B
24 Completed A Randomized Double Blind Protocol Comparing Amphotericin B With Flucytosine to Amphotericin B Alone Followed by a Comparison of Fluconazole and Itraconazole in the Treatment of Acute Cryptococcal Meningitis
Conditions: Meningitis, Cryptococcal;   HIV Infections
Interventions: Drug: Itraconazole;   Drug: Flucytosine;   Drug: Fluconazole;   Drug: Amphotericin B
25 Terminated Efficacy and Safety of Mycograb as Adjunctive Therapy for Cryptococcal Meningitis in Patients With AIDS
Condition: Cryptococcal Meningitis
Interventions: Biological: Efungumab (Mycograb);   Biological: placebo;   Biological: Amphotericin B;   Biological: 5 flucytosine
26 Unknown  Early Versus Delayed Antiretroviral Therapy (ART) in the Treatment of Cryptococcal Meningitis in Africa
Conditions: Cryptococcal Meningitis;   HIV Infections
Interventions: Drug: Fluconazole;   Drug: Fixed dose - Stavudine, lamivudine and Nevirapine;   Drug: Fixed dose - Stavudine, Lamivudine, Nevirapine
27 Completed Safety and Antifungal Activity of Recombinant Interferon-Gamma 1b (rIFN-Gamma 1b) Given With Standard Therapy in Patients With Cryptococcal Meningitis
Conditions: Meningitis, Cryptococcal;   HIV Infections
Interventions: Drug: Itraconazole;   Drug: Flucytosine;   Drug: Fluconazole;   Drug: Amphotericin B;   Drug: Interferon gamma-1b
28 Completed The Safety and Effectiveness of RMP-7 Plus Amphotericin B in Patients With HIV and Cryptococcal Meningitis
Conditions: Meningitis, Cryptococcal;   HIV Infections
Interventions: Drug: Lobradimil;   Drug: Amphotericin B
29 Recruiting High-Dose Fluconazole for the Treatment of Cryptococcal Meningitis in HIV-Infected Individuals
Conditions: Cryptococcal Meningitis;   HIV Infections
Interventions: Drug: Fluconazole;   Drug: Amphotericin B
30 Completed Clinical Outcomes of Cryptococcal Meningitis Among HIV-infected Patients in the Era of Antiretroviral Therapy
Conditions: Cryptococcal Meningitis;   HIV/AIDS
Intervention:
31 Terminated Efficacy and Safety of Mycograb as Adjunctive Therapy for Cryptococcal Meningitis in Patients With AIDS
Condition: Cryptococcal Meningitis
Interventions: Drug: Mycograb;   Drug: placebo
32 Recruiting Liposomal Amphotericin B for the Treatment of Cryptococcal Meningitis
Condition: Cryptococcal Meningitis
Interventions: Drug: Liposomal amphotericin B;   Drug: Amphotericin B-deoxycholate
33 Recruiting Adjunctive Sertraline for the Treatment of HIV-Associated Cryptococcal Meningitis
Conditions: Cryptococcal Meningitis;   Fungal Meningitis
Intervention: Drug: Sertraline
34 Active, not recruiting Study Evaluating Efficiency and Tolerance of High-dose Fluconazole Associated With Flucytosine as Induction Therapy for Cryptococcal Meningitis Associated With HIV in Sub-saharan Africa
Conditions: Cryptococcal Meningitis;   HIV
Interventions: Drug: Fluconazole;   Drug: Flucytosine;   Procedure: lumbar punctures
35 Active, not recruiting Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases in Neurological Disorders in DRC
Conditions: Neurological Disorders;   Cerebral Malaria;   Bacterial Meningitis;   Central Nervous System Tuberculosis;   Neurosyphilis;   Cryptococcal Meningitis
Interventions: Device: Immunochromatographic HAT tests (DSD);   Device: Card Agglutination Trypanosoma Test;   Device: TB POC Nucleic Acid Amplification Test (Molbio Diagnostics);   Device: TB 3-marker RDT (Tulip diagnostics);   Device: Cryptococcal Antigen Lateral Flow Assay (Immy)
36 Completed
Has Results
Amphotericin Alone or in Combination With Fluconazole for AIDS-Associated Meningitis
Condition: Cryptococcal Meningitis
Interventions: Drug: Amphotericin B;   Drug: Fluconazole
37 Completed Optimal Time to Start Antiretroviral Therapy in HIV-infected Adults With Cryptococcal Meningitis
Conditions: Cryptococcal Meningitis;   HIV Infections
Intervention: Other: Early antiretroviral therapy
38 Recruiting Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ Lymphocytopenia
Conditions: Idiopathic CD4+ Lymphocytopenia;   Cryptococcal Meningitis;   Warts
Intervention:
39 Completed Open Label Study of Posaconazole in the Treatment of Invasive Fungal Infections (Study P00041)
Condition: Mycoses
Intervention: Drug: Posaconazole
40 Completed Study of Posaconazole in the Treatment of Invasive Fungal Infections (Study P02095)
Condition: Mycoses
Intervention: Drug: Posaconazole oral suspension

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-41) Show next page of results    Last Page
Indicates status has not been verified in more than two years